| Name | Stillwater Health Care |
|---|---|
| Location | 335 Stillwater Ave, Bangor, Maine |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 63 |
| Occupancy Rate | 78.57% |
| Medicare ID (CCN) | 205116 |
| Legal Business Name | Shc Llc |
| Ownership Type | For Profit - Corporation |
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Politico: Process is principle in Washington right now, as parliamentary procedure attorneys "clash" over the legal designations and wording of various bills and provisions in the lead up to an attempt to pass health legislation under filibuster-avoiding reconciliation rules. "High drama" and "historic" vote calls are likely, but for now it's the conclusions that come from "behind-the-scenes conversations" that will be center stage.
A multicenter research team has announced encouraging results for an experimental therapy using elements of the body's immune system to improve cure rates for children with neuroblastoma, a challenging cancer of the nervous system.
Babies with an eye-alignment disorder called infantile esotropia have delays in motor development milestones, but development "catches up" after corrective surgery, reports a study in the April Journal of AAPOS (American Association for Pediatric Ophthalmology and Strabismus).
Patients taking the lipid-lowering medications atorvastatin, pravastatin, and simvastatin to reduce cholesterol levels, have a relatively low risk of developing rhabdomyolysis, (a disorder that causes the breakdown of muscle), according to a new study in the December 1 issue of JAMA.
Akela Pharma, Inc., a drug development company with its lead product, Fentanyl TAIFUN, being developed for the treatment of breakthrough cancer pain and the company's wholly owned subsidiary, PharmaForm, a leading specialty contract service provider in the area of pharmaceutical dosage form development and manufacturing, today announced its financial results for the three months and year ended March 31, 2011.
› Verified 3 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $7345 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 12.5 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 8.67 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 76.36 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.12 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 6.57 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 13.82 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.47 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 24.74 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 81.68 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.57 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 22.36 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 13.64 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 7.45 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.72 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 57.04 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 86.82 | 82.93 |
News Archive
Politico: Process is principle in Washington right now, as parliamentary procedure attorneys "clash" over the legal designations and wording of various bills and provisions in the lead up to an attempt to pass health legislation under filibuster-avoiding reconciliation rules. "High drama" and "historic" vote calls are likely, but for now it's the conclusions that come from "behind-the-scenes conversations" that will be center stage.
A multicenter research team has announced encouraging results for an experimental therapy using elements of the body's immune system to improve cure rates for children with neuroblastoma, a challenging cancer of the nervous system.
Babies with an eye-alignment disorder called infantile esotropia have delays in motor development milestones, but development "catches up" after corrective surgery, reports a study in the April Journal of AAPOS (American Association for Pediatric Ophthalmology and Strabismus).
Patients taking the lipid-lowering medications atorvastatin, pravastatin, and simvastatin to reduce cholesterol levels, have a relatively low risk of developing rhabdomyolysis, (a disorder that causes the breakdown of muscle), according to a new study in the December 1 issue of JAMA.
Akela Pharma, Inc., a drug development company with its lead product, Fentanyl TAIFUN, being developed for the treatment of breakthrough cancer pain and the company's wholly owned subsidiary, PharmaForm, a leading specialty contract service provider in the area of pharmaceutical dosage form development and manufacturing, today announced its financial results for the three months and year ended March 31, 2011.
› Verified 3 days ago
Westgate Center For Rehab & Alzheimers Care Location: 750 Union St, Bangor, Maine 04401 Phone: (207) 942-7336 | |
Eastside Center For Health & Rehabilitation, Llc Location: 516 Mt Hope Avenue, Bangor, Maine 04401 Phone: (207) 947-6131 | |